BCG – Page 7 – Communicable Diseases Research

Diverse Manifestations of COVID-19: Some Suggested Mechanisms

Review

Published on 2021-09-172022-10-30
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions

COVID-19 팬데믹 및 백신 관련 과제 및 해결 방법 업데이트

Review

Published on 2021-09-102022-09-11
Journal: Frontiers in Cellular and Infection Microbiology [Category] MERS, SARS, 변종,

[키워드] ACE-2 receptor acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 all age group all age groups Alpha Antibody-dependent enhancement approach approval approved attenuated vaccine Attenuated Virus B.1.1.7 B.1.351 B.1.429 B.1.525 B.1.617 B.1.617.2 BCG being Beta booster dose candidate vaccine caused CD8 challenge China city clinical development clinical trial combating Compliance contrary Coronaviridae family coronavirus coronavirus disease Coronavirus-2 COVID-19 CTL Delta disease severity Effectiveness Efficacy elicit Emergency use Epsilon Eta Gamma herd immunity host cells immune activation immune response immune responses Immunity inactivated Inactivated Vaccines inhibit intracellular pathogen Live attenuated vaccine MOST Multiple multiple antigens multivariant vaccines Mutation mutations Neutralizing antibodies neutralizing antibody nucleic acids pandemic pathogen Phase III clinical trials platform potential limitations Prophylactic Replication Resolution RNA virus SARS CoV-2 variant SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Spike protein subunit vaccines T cell the Coronaviridae Vaccine vaccine candidate Vaccine hesitancy Vaccines variant variants Viral Viral antigen viral antigens viral entry viral spike protein viral vectors virus viruses WHO Wuhan
[DOI] 10.3389/fcimb.2021.690621 PMC 바로가기 [Article Type] Review

Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19

저렴하고 평범한 것: COVID-19에서 BCG 및 γδ T 세포에 대한 사례 만들기

Immunology

Published on 2021-09-082022-09-11
Journal: Frontiers in Immunology [Category] SARS, 변종,

[키워드] adaptive immune system antibodies Antigen Antiviral approach assist Bacille Calmette-Guérin vaccine BCG BCG vaccination bcg vaccine build country COVID-19 COVID-19 pandemic Cytokines cytotoxicity death Defense Efficacy Gamma gamma delta T cell infected cells innate immune response Innate immunity ligands Making mechanisms Mutation new SARS-CoV-2 non-specific non-specific immunity pro-inflammatory cytokines rapid expansion receptor respiratory respiratory viruses SARS-CoV-2 SARS-CoV-2 variants shown T cell T cells trained immunity Tuberculosis tuberculosis disease undergo Vaccine variant variants
[DOI] 10.3389/fimmu.2021.743924 PMC 바로가기 [Article Type] Immunology

Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, Canada

Article

Published on 2021-08-112023-06-16
Journal: Vaccine [Category] MERS, SARS,

[키워드] BCG COVID-19 SARS-CoV-2 vaccine effectiveness
[DOI] 10.1016/j.vaccine.2021.08.019 PMC 바로가기 [Article Type] Article

BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity

Immunology

Published on 2021-08-052022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

Effect of BCG vaccination on proinflammatory responses in elderly individuals

Research Article

Published on 2021-08-042022-10-28
Journal: Science Advances [Category] COVID-19, MERS, SARS,

The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study

COVID-19의 발생 및 심각성에서 나병 관련 임상 및 역학 변수의 영향 : 예비 실제 코호트 연구

Research Article

Published on 2021-07-282022-09-10
Journal: PLoS Neglected Tropical Diseases [Category] SARS, 치료기술, 한센병,

[키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis Bacillus BCG BCG vaccination caused Chain Reaction Clofazimine cohort study Contact contact with coronavirus coronavirus disease Coronavirus disease 2019 Corticosteroids COVID-19 COVID-19 pandemic Cox proportional hazard Cox proportional hazards model dapsone dependent on diabetes Diabetes Mellitus diagnosed Effect epidemiological Follow-up hazard ratio household contact immune Infection Infectious disease Inflammatory response Interaction leprosy limitations mediators Multivariate analysis Mycobacterium leprae Mycobacterium lepromatosis not affect Occurrence outcome Patient patients Pentoxifylline performed polymerase chain polymerase chain reaction proportional hazards model Protective effects reported respiratory reverse transcription reverse transcription polymerase chain reaction risk risk factor RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-infected patients severe acute respiratory syndrome Coronavirus severity severity of COVID-19 survival analysis thalidomide therapy Treatment use of corticosteroids vaccination variable was used with COVID-19
[DOI] 10.1371/journal.pntd.0009635 PMC 바로가기 [Article Type] Research Article

The Global Interest in Vaccines and Its Prediction and Perspectives in the Era of COVID-19. Real-Time Surveillance Using Google Trends

코로나19 시대 백신에 대한 세계적 관심과 예측과 전망. Google 트렌드를 사용한 실시간 감시

Article

Published on 2021-07-242022-09-10
Journal: International Journal of Environmental Research an [Category] SARS, 치료기술,

Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?

Short communication

Published on 2021-07-012022-10-05
Journal: The Indian journal of tuberculosis [Category] SARS, 임상,

BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial

우간다 신생아의 이종 감염성 질환에 대한 BCG- 유도 비특이적 영향 : 조사관 맹인 무작위 대조 시험

Articles

Published on 2021-07-012022-09-06
Journal: The Lancet. Infectious Diseases [Category] Communicable Disease,

[키워드] 1:1 Abstract addition age all-cause mortality Alter analysed analyses assigned BCG BCG vaccination benefit Birth blind block size block sizes blood sample Blood samples change clinically clinician Comparisons computer-generated Concentration Consent contributed Controlled Controlled trial Cord blood discharged Effect Effects eligible enrolled Entebbe Families finding Follow-up for inclusion funding geometric geometric mean geometric mean ratios gestational age group hazard ratio healthy hepcidin Heterologous hospital IFNγ IL-10 IL-1β IL-6 IL1B IL6 immunological incidence increase in Infant Infants infections Infectious disease inhibited Innate immunity international standard investigated investigators life Luganda material medical intervention modified intention-to-treat mononuclear cell morbidity morbidity and mortality mother Neonatal neonatal period no significant difference non-specific number outcome parent parents participant Peripheral blood Peripheral blood mononuclear cells primary clinical outcome promoter promoter region PROTECT randomisation randomised randomised controlled trial Randomly receive recruited reduce reductions reductions in Registered required saturation Standard Standard dose stratified by sex TNF Transferrin translation Trial Tuberculosis Uganda vaccination Wellcome Trust were excluded with HIV withdrawn
[DOI] 10.1016/S1473-3099(20)30653-8 PMC 바로가기 [Article Type] Articles